Morning
Yeah doc, thanks for your opinion however I question your post as you are an NUH shareholder. I know @bruutz82 made another comment on your forum yesterday and I know a lot of you shareholders from that forum are playing tit for tat... 'My shares are better than yours' kind of approach. It's quite childish to be honest. I question that you are even a doctor?! And that you have an autistic child I don't believe anything you say, sorry. By the way regarding this comment - "This makes outcome measures from studies vulnerable to bias and therefore need strict controls and process (like double blinding)" exactly what the company has done mate NTI's study was double blind and the results will be telling. The preliminary results were outstanding there's no denying that...
I see another one of your friends from guess what?! NUH downplayed this again yesterday. Or was it the same guy behind the post? Anyway good luck with your investment, when these results are published for NTI.....
Cheers
Red bar
NTI Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
